Publication Type: Peer-Reviewed
-
Validation of a blood-based autoantibody test to assess lung cancer risk in 4–30 mm pulmonary nodules: a retrospective pooled analysis of four cohort studies
-
Validation of a High-Specificity Blood Autoantibody Test to Detect Lung Cancer in Pulmonary Nodules
-
Lung cancer associated autoantibody responses are detectable years before clinical presentation
-
Molecular and Translational Biology of the Blood-Based VeriStrat Proteomic Test Used in Cancer Immunotherapy Treatment Guidance
-
Using a Blood Biomarker to Distinguish Benign From Malignant Pulmonary Nodules
-
Impact of an integrated classifier using biomarkers, clinical and imaging factors on clinical decisions making for lung nodules
-
Assessing a biomarker’s ability to reduce invasive procedures in patients with benign lung nodules: Results from the ORACLE study
-
Analytic and Clinical Validation of a Pan-Cancer NGS Liquid Biopsy Test for the Detection of Copy Number Amplifications, Fusions and Exon Skipping Variant
-
Explaining multivariate molecular diagnostic tests via Shapley values
-
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer